Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Molecular Medicine (Berlin, Germany)|October 28, 2014
Transcriptomic profiling facilitates classification of response to influenza challengeEmma E Davenport, Richard D Antrobus, Patrick J Lillie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 31, 2013
Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigensRichard D Antrobus, Lynda Coughlan, Tamara K Berthoud, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 9, 2013
Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responsesRichard D Antrobus, Tamara K Berthoud, Caitlin E Mullarkey, et al.
The Journal of Infectious Diseases|May 5, 2005
Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex moleculesRichard D Antrobus, Naeem Khan, Andrew D Hislop, et al.
The Lancet. Infectious Diseases|August 25, 2014
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trialIman Satti, Joel Meyer, Stephanie A Harris, et al.
Plos One|November 3, 2012
A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 yearsRichard D Antrobus, Patrick J Lillie, Tamara K Berthoud, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
Science Translational Medicine|November 8, 2014
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memoryLeo Swadling, Stefania Capone, Richard D Antrobus, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humansSusanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Pageof 1